©ñ¤j¹Ï¤ù
±ç¦ë
ÁöµM¬ü°êªº¦Ñ¤HªÀ·|ºÖ§Q©MÂåÀø«O»Ù¤w¦s¦b«Üªø®É¶¡¡A¦ý¦b¹L¥h¤G¤T¤Q¦~¡A¬ü°ê¤H¤]ÀHþÓ¾ãÅé¤H¤f¹Ø©R©µªø¤Î¤H¤f¥[³t¦Ñ¤Æ¡A¨Ï±o°·±dÅ@²zªºè©Ê»Ý¨D·U¨Ó·U©úÅã¡A¤ñ¦p¬ü°êºÊºÞ¾÷ºc¨ú®ø«d´îÁp¨¹ÂåÀø«OÀI¶O¥Îp¹ºªº¿EÀy¡A´NÅýµÇŦÅ@²zªA°È¤½¥qDaVita Healthcare PartnersªºªÑ»ùº¦¤F6%¤§¾l¡A±a°Ê°·±dÂåÀøªO¶ôªÑ¦¬¬õº¦0.09%¡CÕY§ë¸êªÌ¼¥¼©°·±dÂåÀøªO¶ôªº§l¤Þ¤O¡AÁÙ·|¦³§Q¨äªO¶ô«á¥«°Ê¯à¡A¤£§«¯d·N§G§½«ØÜ¡C
¦¦b70¦~¥N¡A¬ü°ê¦Ñ¤H¦pªG»ÝnÂåÀøÅ@²z·ÓÅU¡A¤@¯ëªº¿ï¾Ü´N¬O¶i¤J¶Ç²ÎÂåÀø°t³Æ¥R¨¬ªº¡u¦Ñ¤H°|¡v¡C¤£¹L¡AÀHþÓ¤H̥ͩR¤£Â_©µªø¦Ó¼W¥[ªºÅ@²z»Ýn¡A¶Ç²Îªº¦Ñ¤H°|´NÅܱo¶V¨£¤£¨¬¡A¨Ï±o°·±dÂåÀøªO¶ô²[»\¥]¬AÂåÃij]³Æ¨ÑÀ³°Ó¡BÂåÀø«OÀI°Ó¡B»sÃĤ½¥q¤ÎÂå°|µ¥¼sÁï½d³ò¡C
ÀHþÓ¥þ²y¤H¤f¦Ñ¤Æ¤Î¤H§¡¹Ø©R¤£Â_¤W¤É¡A¥«³õ¹ï°·±dÅ@²z²£«~ªº»Ý¨D¤£Â_¼W¥[¡A¥H¤Î¬ü°êªº°·±dÅ@²z¥«³õµo®i¸û§¹µ½¡A¦]¦¹°·±dÅ@²z·~¤]¶¶²z¦¨³¹¦¨¬°¬ü°ê¸gÀÙ´_µd¤¤¡A¼Wªø³Ì¨³³tªº¦æ·~¡C
°·±dÅ@²zªO¶ô¶]Ĺ¼Ð´¶
¦Ó¦b¼Ð´¶500(SPX)¤W©P¤«¤W1,800ÂIªº·í¤Ñ¡ASPXÁöµM¬Oº¦¤F1.12%¡A¦ý¼Ð´¶ªº°·±dÅ@²zªO¶ô»P¯Ã¥æ©Òªº°·±dÅ@²zªO¶ô«ü¼Æ«oÂùÂùº¦¤F1.2%¡A·í¤¤Auxilium Pharmaceuticals ( AUXL ) ªºªvÀø³±²ôµwµ²¯gªº½¦ìžJ·»²Õ´±ôµßÃĪ«¡uXiaflex¡v¡A§@¬°¬ü°ê¹«~©MÃĪ«ºÞ²z§½º°¦§åãªvÀø³oºØ¯gª¬ªºÃĪ«¡A´NÅýAUXLªÑ»ù¤W©P¤³æ¤éº¦12.3%¡Aªí©ú¥un¦³¼sÁ參³õ¡A´N·|Åý¥ø·~«á¥«²K¼¥¼©°Ê¯à¡C
¥H¦ûªñ¤TÓ¤ëº]ºªº¨©µÜ¼w¥@¬É°·±d¬ì¾Ç°òª÷¬°¨Ò¡A¥Dn¬O³z¹L¤£¤Ö©ó70%ªºÁ`¸ê²£§ë¸ê©óÂåÀø«O°·¡BÃÄ«~¡BÂåÀø§Þ³N»P¨ÑÀ³¥H¤Î¥Íª«§Þ³Nµo®iªº¤½¥qÃÒ¨éºÞ²z²Õ¦X¡A¥HºÉ¶q´£°ªÁ`¦^³ø¬°¥Ø¼Ð¡C
°òª÷¦b2010¡B2011©M2012¦~ªí²{¤À§O¬°1.59%¡B5.46%¤Î16.89%¡C°òª÷¥§¡¥«¬Õ²v©M¼Ð·Ç®t¬°21.02¿¤Î13.33%¡C
¸ê²£¦æ·~¤ñ«¬°37.8% »sÃÄ¡B27% ¥Íª«§Þ³N»PÂåÀø¡B20.4% «O°·²£«~»PÂåÀø²£«~¡B12.2%°·±dÅ@²z¤Î0.1% ¨ä¥L¦æ·~¡C
¸ê²£¦Ê¤À¤ñ¬°97.5% ªÑ²¼¤Î2.5% ³f¹ô¥«³õ¡C¸ê²£¦a°Ï¤À¥¬¬°79.4% ¬ü°ê¡B16.9% ¼Ú¬w¡B1% ¤é¥»¤Î0.2% ·s¿³¥«³õ¡C°òª÷¤T¤j¸ê²£¤ñ«ªÑ²¼¬°5.3% ±j¥Í¡B4.4% Celgene¤Î4.4% ù¤ó¡C
|